Chronic renal failure classified as stage 1-4 (mild impairment to pre-end stage renal disease, Levey et al., 2003)
Conditions
Interventions
Trade Name: Inutest 25%
Product Name: Inutest 25%
Product Code: Inutest 25%
Pharmaceutical Form: Concentrate for solution for injection
Sponsors
Conwy and Denbighshire NHS Trust
North West Wales NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Chronic renal failure classified as stage 1-4 (mild impairment to pre-end stage renal disease, Levey et al., 2003) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: age <18yrs, previous renal replacement therapy, cardiac pacemakers, diabetes, inability to provide informed consent, current breastfeeding or pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To test the hypothesis that when estimating kidney function in patients with chronic renal failure, using more precise measures of muscle mass, instead of traditional indirect determinants such as sex, age, height, weight and ethnicity, will improve the accuracy of the estimation.;Secondary Objective: To determine the effects (if any) of age, gender, height and weight on renal function, which are independent of their effects on muscle mass. ;Primary end point(s): Glomerular filtration rate, serum creatinine, appendicular muscle mass, intra cellular water, demographic data (gender, age, height, weight) | — |
Countries
United Kingdom
Outcome results
None listed